Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Synthetic Cannabinoids (K2 / Spice)

Are Synthetic Cannabinoids (K2 / Spice) legal in Armenia?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Not applicable as a class status for Armenia. The applicability answer holds and the evidence the applied cell gave for it is corrected. The label names an open structural family with no fixed membership, and the հավելված to Government Decision N 1129-Ն of 21 August 2003 answers by printed line, so an identified molecule is required before any line can be matched. That much stands. The applied cell then described the annex as carrying named substances and one isomer clause, the clause reaching all isomers of tetrahydrocannabinol, «Տետրահիդրոկանաբինոլի բոլոր իզոմերները», and reported that a search under one named compound found nothing. The second half is wrong. Ցուցակ N 1 prints a long uninterrupted run of individually named synthetic cannabinoids, beginning at ACBM-018 and running through the AM, CP, HU, JWH and MDMB series, and the compound the applied cell searched for is in it: «JWH-018» is printed against «1-պենտիլ-3-(նաֆթալին-1-իլ) ինդոլ», between JWH-015 and JWH-019. The applicability conclusion survives that correction because the run is an enumeration. Unlike its neighbours in this set, this annex carries no clause reaching a synthetic cannabinoid structural group at group level, and the one family clause it does carry is about the isomers of a natural cannabinoid. Read on 21 September 2026.
Consequences if caught
Capital exposure: none. Armenia has abolished the death penalty and Article 393 of the Criminal Code of the Republic of Armenia provides no life sentence for a drug offence, so the real exposure is a term of years. The 12 year ceiling under Article 393(3) and the bands at Article 393(4) to (6) apply to a listed substance, and the exposure follows each constituent actually identified rather than the label on the package. The correction to make is that identifying the constituent is far more likely to produce a placement than the applied cell implied, because Ցուցակ N 1 prints a long run of these compounds by name and the prohibited list is where they sit. A compound made after the last amendment read here may still have no line at all, which is what keeps the family question open at family level.
If prescribed or medical
Armenia states no lawful personal use allowance for a scheduled substance, and Article 393(4) to (6) measures its significant, large and especially large bands from the minimum small amount figure the Government sets, which is a criminal threshold and never a traveller quota. A scheduled medicine must in addition satisfy the law on medicines, «Դեղերի մասին» Հայաստանի Հանրապետության օրենք, together with the prescription, packaging, import and customs rules that law carries. There is no class placement for this row, because the annex carries named lines and one clause about the isomers of a natural cannabinoid, neither of which bounds an open family. Where a constituent is identified it will usually be found among the named synthetic cannabinoids of Ցուցակ N 1, and that is the prohibited list, so no medicinal route runs through it. The enquiry has to name a molecule.
Documentation
Carry nothing on the strength of the label, because the label is what this row declines to resolve. Identify the constituent, carry the paperwork that constituent needs, and put the question to the Armenian Ministry of Health or the nearest Armenian embassy before travelling. Ask about the compound by its code name as the annex prints it, because Ցուցակ N 1 prints these compounds under their Latin code names with the Armenian chemical description beneath, and the annex carries no Chemical Abstracts numbers and no serial numbers. The annex can be amended, so recheck before travel. Read on 21 September 2026.
Primary sources
  • Armenia, synthetic cannabinoids, applicability answer retained and its evidence corrected
  • Ցուցակ N 1 prints a long run of individually named synthetic cannabinoids beginning at ACBM-018 and running through the AM, CP, HU, JWH and MDMB series
  • printed member relied on for the reading, «JWH-018» against «1-պենտիլ-3-(նաֆթալին-1-իլ) ինդոլ», between JWH-015 and JWH-019
  • the applied cell's report that this compound returned nothing is falsified, and its description of the annex as carrying named substances and one isomer clause understates the run
  • the one family clause the annex carries is «Տետրահիդրոկանաբինոլի բոլոր իզոմերները», about a natural cannabinoid, and no clause reaches a synthetic cannabinoid structural group at group level, which is why the applicability answer holds
  • the lists are alphabetical and carry no serial numbers and the annex prints no Chemical Abstracts numbers
  • Government Decision N 1129-Ն of 21 August 2003, հավելված, ցուցակներ N 1 to N 4, official incorporation as amended to 23.04.25 N 473-Ն, read at https://www.arlis.am/hy/acts/205965 on 21 September 2026, together with amendment N 334-Ն of 26 March 2026 in force 27 March 2026, read at https://www.arlis.am/en/acts/222947 on the same day
  • The incorporation carries amendments up to 23.04.25 N 473-Ն and does not yet carry N 334-Ն, which was read separately. N 334-Ն adds four nitazenes to Ցուցակ N 1 and adds Կարիսոպրոդոլ and Հեքսահիդրոկանաբինոլ to Ցուցակ N 3, and touches none of the four substances in this set
  • Armenian script forms searched: սինթետիկ, կանաբինոիդ, կաննաբինոիդ, ինդոլ, ինդազոլ, and the Latin JWH
  • penalties at the Criminal Code of the Republic of Armenia, Article 393(3) for the 12 year ceiling and Article 393(4) to (6) for the bands measured from the Government's minimum small amount figure
  • arlis.am
  • arlis.am
  • arlis.am
  • arlis.am

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Armenia